MEDEXUS PHARMACEUTICALS INC (modificare)
Versiunea de la data 17 noiembrie 2024 08:55
, 17 noiembrieThe LinkTitles extension automatically added links to existing pages (https://github.com/bovender/LinkTitles).
(The LinkTitles extension automatically added links to existing pages (https://github.com/bovender/LinkTitles).) |
(The LinkTitles extension automatically added links to existing pages (https://github.com/bovender/LinkTitles).) |
||
| Linia 2: | Linia 2: | ||
==Descriere companie== | ==Descriere companie== | ||
Medexus Pharmaceuticals Inc. (https://www.medexus.com/en_US) is a Canada-based rare disease pharmaceutical company. The Company is a North American focused, specialty pharmaceutical business that operates through two divisions: Medexus [[PHARMA|Pharma]] Canada and Medexus Pharma USA. Medexus Pharma Canada, a fully integrated commercial infrastructure focused on rheumatology, allergy, auto-immune disease, specialty oncology and pediatric diseases in Canada. Medexus Pharma USA, a fully integrated commercial infrastructure focused on rheumatology and auto-immune diseases in the United States (U.S). The Company is focused on the therapeutic areas of auto-immune disease, hematology, pediatrics, dermatology and allergy. The Company's products are Rasuvo and Metoject, a formulation of methotrexate (auto-pen and pre-filled syringe) designed to treat rheumatoid arthritis and other auto-immune diseases. It also offers IXINITY, a medicine for use in patients 12 years of age or older with Hemophilia B and Rupall, an allergy medication. | Medexus Pharmaceuticals Inc. (https://www.medexus.com/en_US) is a Canada-based rare disease pharmaceutical company. The Company is a North American focused, specialty pharmaceutical business that operates through two divisions: Medexus [[PHARMA|Pharma]] Canada and Medexus [[PHARMA|Pharma]] USA. Medexus Pharma Canada, a fully integrated commercial infrastructure focused on rheumatology, allergy, auto-immune disease, specialty oncology and pediatric diseases in Canada. Medexus Pharma USA, a fully integrated commercial infrastructure focused on rheumatology and auto-immune diseases in the United States (U.S). The Company is focused on the therapeutic areas of auto-immune disease, hematology, pediatrics, dermatology and allergy. The Company's products are Rasuvo and Metoject, a formulation of methotrexate (auto-pen and pre-filled syringe) designed to treat rheumatoid arthritis and other auto-immune diseases. It also offers IXINITY, a medicine for use in patients 12 years of age or older with Hemophilia B and Rupall, an allergy medication. | ||
==Grafic actiuni companie== | ==Grafic actiuni companie== | ||